Published online Sep 22, 2017. doi: 10.5498/wjp.v7.i3.133
Peer-review started: March 29, 2017
First decision: May 9, 2017
Revised: June 8, 2017
Accepted: June 30, 2017
Article in press: July 3, 2017
Published online: September 22, 2017
Core tip: Anxiety disorders are some of the most commonly comorbidly- and mis-diagnosed disorders in the DSM-5. The current system of assessment and diagnosis depends on clinician and client report measures, which are subjective and prone to bias. Recent technological advances make it possible to utilize the biobehavioral measures from eye-tracking and electrocardiogram devices in clinical settings. These devices can provide a much needed dimensional, objective, and change-sensitive component to current diagnostic and treatment-efficacy assessment protocols. This article summarizes the status of and outlines future directions for research on this important topic.